GENE ONLINE|News &
Opinion
Blog

Incyte Corporation
Trials & Approvals Incyte CorporationAnti-PD-1
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Trials & Approvals Oncology
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
Licensing cGVHD
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
Trials & Approvals FDA Approval
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
Licensing Monoclonal Antibody
China’s InnoCare, Incyte Enter Collaboration And License Deal for Monoclonal Antibody in Greater China
2021-08-18
Trials & Approvals Checkpoint Inhibitor
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
COVID-19 JAK1 Inhibitor
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
Trials & Approvals
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
Trials & Approvals Alopecia Areata
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
Trials & Approvals JAK/STAT
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
LATEST
Crossing Borders for a New Era in Healthcare Quality: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top